Back to Trades
DeMuth Peter
Chief Scientific OfficerCIK 0001979163
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 2
- Buy transactions
- 0
- Sell transactions
- 0
- Companies
- 1
- Active
- 2025–2026
DeMuth Peter, Chief Scientific Officer, accounts for 2 disclosed filings worth $172.3K, all concentrated in Elicio Therapeutics, Inc. (ELTX), active 2025–2026. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
2 loaded
| Jul 17 | ELTX Elicio Therapeutics, Inc. | DeMuth Peter | Chief Scientific Officer | Award | $169.1K |
| Dec 10 | ELTX Elicio Therapeutics, Inc. | DeMuth Peter | Chief Scientific Officer | Exercise | $3.2K |
2 filings